| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-tyrosine sulfotransferase activity | 1.51e-05 | 2 | 78 | 2 | GO:0008476 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine sulfation | 1.45e-05 | 2 | 79 | 2 | GO:0006478 | |
| Domain | TPST | 1.72e-05 | 2 | 78 | 2 | IPR026634 | |
| Domain | NSL3/Tex30 | 1.72e-05 | 2 | 78 | 2 | IPR026555 | |
| Domain | TM_Fragile-X-F-assoc | 1.03e-04 | 4 | 78 | 2 | IPR019396 | |
| Domain | Tmemb_185A | 1.03e-04 | 4 | 78 | 2 | PF10269 | |
| Domain | AA_TRANSFER_CLASS_2 | 2.55e-04 | 6 | 78 | 2 | PS00599 | |
| Domain | Aminotrans_II_pyridoxalP_BS | 2.55e-04 | 6 | 78 | 2 | IPR001917 | |
| Domain | DOCK_C | 9.24e-04 | 11 | 78 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 9.24e-04 | 11 | 78 | 2 | IPR027007 | |
| Domain | DHR_2 | 9.24e-04 | 11 | 78 | 2 | PS51651 | |
| Domain | DHR_1 | 9.24e-04 | 11 | 78 | 2 | PS51650 | |
| Domain | DOCK-C2 | 9.24e-04 | 11 | 78 | 2 | PF14429 | |
| Domain | DHR-2 | 9.24e-04 | 11 | 78 | 2 | IPR027357 | |
| Domain | DHR-2 | 9.24e-04 | 11 | 78 | 2 | PF06920 | |
| Domain | DOCK | 9.24e-04 | 11 | 78 | 2 | IPR026791 | |
| Domain | Aminotransferase_I/II | 2.25e-03 | 17 | 78 | 2 | IPR004839 | |
| Domain | Aminotran_1_2 | 2.25e-03 | 17 | 78 | 2 | PF00155 | |
| Domain | AAA+_ATPase | 3.11e-03 | 144 | 78 | 4 | IPR003593 | |
| Domain | AAA | 3.11e-03 | 144 | 78 | 4 | SM00382 | |
| Domain | - | 3.83e-03 | 746 | 78 | 9 | 3.40.50.300 | |
| Domain | - | 4.73e-03 | 81 | 78 | 3 | 3.90.550.10 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION | 6.53e-05 | 57 | 54 | 4 | MM14634 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION | 8.54e-05 | 61 | 54 | 4 | M26993 | |
| Pubmed | 4.40e-06 | 549 | 79 | 9 | 38280479 | ||
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 5.02e-06 | 558 | 79 | 9 | 35063084 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19261907 | ||
| Pubmed | Effects of CACNA1C and ANK3 on cognitive function in patients with bipolar disorder. | 5.09e-06 | 2 | 79 | 2 | 38657895 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21676128 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 22745813 | ||
| Pubmed | No association between bipolar disorder risk polymorphisms in ANK3 and CACNA1C and common migraine. | 5.09e-06 | 2 | 79 | 2 | 21395576 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 28874591 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 22647524 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 12404111 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 24108394 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16859706 | ||
| Pubmed | Genetic analysis of SNPs in CACNA1C and ANK3 gene with schizophrenia: A comprehensive meta-analysis. | 5.09e-06 | 2 | 79 | 2 | 26227746 | |
| Pubmed | Structural basis for the broad substrate specificity of the human tyrosylprotein sulfotransferase-1. | 5.09e-06 | 2 | 79 | 2 | 28821720 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 17046811 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23951251 | ||
| Pubmed | Evidence for cis-acting regulation of ANK3 and CACNA1C gene expression. | 5.09e-06 | 2 | 79 | 2 | 20636642 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 9733778 | ||
| Pubmed | Genetic polymorphism of antioxidant enzymes in eosinophilic and non-eosinophilic nasal polyposis. | 5.09e-06 | 2 | 79 | 2 | 27515707 | |
| Pubmed | Shear stress mediates tyrosylprotein sulfotransferase isoform shift in human endothelial cells. | 5.09e-06 | 2 | 79 | 2 | 12056800 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 34704252 | ||
| Pubmed | Ahnak is critical for cardiac Ca(V)1.2 calcium channel function and its beta-adrenergic regulation. | 5.09e-06 | 2 | 79 | 2 | 16319140 | |
| Pubmed | Analysis of ANK3 and CACNA1C variants identified in bipolar disorder whole genome sequence data. | 5.09e-06 | 2 | 79 | 2 | 24716743 | |
| Pubmed | Mass spectrometric kinetic analysis of human tyrosylprotein sulfotransferase-1 and -2. | 5.09e-06 | 2 | 79 | 2 | 18672380 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18243191 | ||
| Pubmed | Tyrosylprotein sulfotransferase-2 expression is required for sulfation of RNase 9 and Mfge8 in vivo. | 5.09e-06 | 2 | 79 | 2 | 19047058 | |
| Pubmed | Tyrosine sulfation is a trans-Golgi-specific protein modification. | 5.09e-06 | 2 | 79 | 2 | 3121635 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21039965 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 KANSL3 CEP170 CACNA1C CPAMD8 ABLIM1 GALNT10 ANK3 EEPD1 TTC12 PANK4 TSPYL2 CPT1A KLHL26 | 5.99e-06 | 1489 | 79 | 14 | 28611215 |
| Pubmed | MicroRNA-30b-mediated regulation of catalase expression in human ARPE-19 cells. | 1.53e-05 | 3 | 79 | 2 | 22880027 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 37597421 | ||
| Pubmed | [Quantifying gene expression in prostate carcinoma. Which endogenous reference genes are suitable?]. | 1.53e-05 | 3 | 79 | 2 | 17628775 | |
| Pubmed | Genetic polymorphisms affecting antioxidant enzymes are present in tympanosclerosis patients. | 1.53e-05 | 3 | 79 | 2 | 27534583 | |
| Pubmed | Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis. | 1.53e-05 | 3 | 79 | 2 | 37424015 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 12169668 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 19679829 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 10497246 | ||
| Pubmed | ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype. | 1.53e-05 | 3 | 79 | 2 | 21767209 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CEP170 ABLIM1 FBL HPRT1 AHNAK POLR2A DOCK7 PSMC5 CAT NUP188 HERC2 | 1.98e-05 | 1024 | 79 | 11 | 24711643 |
| Pubmed | 2.21e-05 | 24 | 79 | 3 | 23728617 | ||
| Pubmed | 2.73e-05 | 383 | 79 | 7 | 29331416 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 21393235 | ||
| Pubmed | 3.30e-05 | 708 | 79 | 9 | 39231216 | ||
| Pubmed | DOCK1 STARD13 KANSL3 CEP170 CPAMD8 TEX30 ANK3 AHNAK PSMC5 CYP7B1 EVPL LRRC36 | 3.40e-05 | 1293 | 79 | 12 | 15342556 | |
| Pubmed | 4.26e-05 | 916 | 79 | 10 | 32203420 | ||
| Pubmed | 4.84e-05 | 31 | 79 | 3 | 22261722 | ||
| Pubmed | Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. | 5.07e-05 | 5 | 79 | 2 | 14738763 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 21633705 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 25155958 | ||
| Pubmed | Reference genes in the developing murine brain and in differentiating embryonic stem cells. | 5.07e-05 | 5 | 79 | 2 | 22735032 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 15525354 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 19242068 | ||
| Pubmed | 5.36e-05 | 177 | 79 | 5 | 26206133 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.55e-05 | 440 | 79 | 7 | 34244565 | |
| Pubmed | α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | 7.01e-05 | 35 | 79 | 3 | 37381005 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 16352659 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 8.11e-05 | 313 | 79 | 6 | 38270169 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 9.00e-05 | 807 | 79 | 9 | 30575818 | |
| Pubmed | 9.76e-05 | 634 | 79 | 8 | 34591612 | ||
| Pubmed | 1.00e-04 | 202 | 79 | 5 | 24639526 | ||
| Pubmed | DDI2 protease controls embryonic development and inflammation via TCF11/NRF1. | 1.05e-04 | 40 | 79 | 3 | 39328932 | |
| Pubmed | SLC35B2 Acts in a Dual Role in the Host Sulfation Required for EV71 Infection. | 1.06e-04 | 7 | 79 | 2 | 35420441 | |
| Pubmed | Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. | 1.06e-04 | 7 | 79 | 2 | 10089882 | |
| Pubmed | 1.14e-04 | 481 | 79 | 7 | 28190767 | ||
| Pubmed | 1.20e-04 | 653 | 79 | 8 | 22586326 | ||
| Pubmed | 1.33e-04 | 493 | 79 | 7 | 15368895 | ||
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 1.36e-04 | 344 | 79 | 6 | 36282215 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SPTBN5 VWA8 FBL PANK4 PSMC5 CAT ALAS1 TAB1 NUP188 HERC2 CLPX EIF2AK3 | 1.36e-04 | 1496 | 79 | 12 | 32877691 |
| Pubmed | Two cell lineages, myf5 and myf5-independent, participate in mouse skeletal myogenesis. | 1.41e-04 | 8 | 79 | 2 | 18331721 | |
| Pubmed | Determination of the sites of tyrosine O-sulfation in peptides and proteins. | 1.41e-04 | 8 | 79 | 2 | 17558413 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KANSL3 TPST2 ABCA2 LLGL2 VWA8 AHNAK POLR2A NUP188 HERC2 SUFU | 1.99e-04 | 1105 | 79 | 10 | 35748872 |
| Pubmed | 2.16e-04 | 534 | 79 | 7 | 35032548 | ||
| Pubmed | RNF8/UBC13 ubiquitin signaling suppresses synapse formation in the mammalian brain. | 2.27e-04 | 10 | 79 | 2 | 29097665 | |
| Pubmed | 2.46e-04 | 245 | 79 | 5 | 35652658 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 2.60e-04 | 732 | 79 | 8 | 34732716 | |
| Pubmed | Genome wide study of maternal and parent-of-origin effects on the etiology of orofacial clefts. | 2.76e-04 | 11 | 79 | 2 | 22419666 | |
| Pubmed | PLEKHM1/DEF8/RAB7 complex regulates lysosome positioning and bone homeostasis. | 2.76e-04 | 11 | 79 | 2 | 27777970 | |
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 2.76e-04 | 11 | 79 | 2 | 20351715 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 2.91e-04 | 139 | 79 | 4 | 25476789 | |
| Pubmed | 2.95e-04 | 255 | 79 | 5 | 15324660 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 3.01e-04 | 949 | 79 | 9 | 36574265 | |
| Pubmed | 3.01e-04 | 399 | 79 | 6 | 37536630 | ||
| Pubmed | Linkage mapping of murine homolog of the yeast SPT6 gene to MMU11B1. | 3.31e-04 | 12 | 79 | 2 | 8662231 | |
| Pubmed | K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation. | 3.31e-04 | 12 | 79 | 2 | 26390156 | |
| Pubmed | Fine mapping of the MHC Class III region demonstrates association of AIF1 and rheumatoid arthritis. | 3.31e-04 | 12 | 79 | 2 | 18835879 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 3.64e-04 | 974 | 79 | 9 | 28675297 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TPST2 TPST1 GALNT10 ABCA2 B4GALT7 NETO2 SPTLC2 TXNDC16 CPT1A EIF2AK3 | 3.85e-04 | 1201 | 79 | 10 | 35696571 |
| Pubmed | CEP170 ABLIM1 VWA8 SPTLC2 AHNAK PANK4 DOCK7 PSMC5 NUP188 CLPX CTPS1 | 4.02e-04 | 1440 | 79 | 11 | 30833792 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 4.06e-04 | 422 | 79 | 6 | 27342126 | |
| Pubmed | 4.55e-04 | 14 | 79 | 2 | 27659424 | ||
| Pubmed | 4.55e-04 | 14 | 79 | 2 | 12432077 | ||
| Pubmed | 4.55e-04 | 14 | 79 | 2 | 15570572 | ||
| Pubmed | 4.60e-04 | 1006 | 79 | 9 | 15226823 | ||
| Pubmed | Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation. | 5.08e-04 | 68 | 79 | 3 | 25754235 | |
| Pubmed | Lead exposure, polymorphisms in genes related to oxidative stress, and risk of adult brain tumors. | 5.25e-04 | 15 | 79 | 2 | 19505917 | |
| Pubmed | Interactomic analysis reveals a homeostatic role for the HIV restriction factor TRIM5α in mitophagy. | 5.47e-04 | 292 | 79 | 5 | 35545034 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 5.50e-04 | 1257 | 79 | 10 | 37317656 | |
| Pubmed | 5.53e-04 | 70 | 79 | 3 | 34255829 | ||
| Pubmed | 5.99e-04 | 16 | 79 | 2 | 21301993 | ||
| Pubmed | A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly. | 5.99e-04 | 16 | 79 | 2 | 24535457 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.83e-08 | 200 | 79 | 7 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.83e-08 | 200 | 79 | 7 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.83e-08 | 200 | 79 | 7 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.83e-08 | 200 | 79 | 7 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.83e-08 | 200 | 79 | 7 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.83e-08 | 200 | 79 | 7 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 9.35e-07 | 184 | 79 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 9.65e-07 | 185 | 79 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.16e-06 | 191 | 79 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.20e-06 | 192 | 79 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-06 | 157 | 79 | 5 | cbb08d5c151f0622123276926a2a15bb7d271e90 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-06 | 157 | 79 | 5 | 16581e2399a211633f870dce326c75ff4b6a5fe6 | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.63e-05 | 178 | 79 | 5 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 180 | 79 | 5 | c54af6fb11484dacd3efa1f10a487376ff820a5e | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 180 | 79 | 5 | 07ac979b21be2425294d9818c48b5a1e6f014c19 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.96e-05 | 185 | 79 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 189 | 79 | 5 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.17e-05 | 189 | 79 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.23e-05 | 190 | 79 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.23e-05 | 190 | 79 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.40e-05 | 193 | 79 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-05 | 193 | 79 | 5 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 194 | 79 | 5 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 194 | 79 | 5 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.52e-05 | 195 | 79 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.65e-05 | 197 | 79 | 5 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.65e-05 | 197 | 79 | 5 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.65e-05 | 197 | 79 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.72e-05 | 198 | 79 | 5 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.72e-05 | 198 | 79 | 5 | a6b942fe850e287e1cb705684e29218072daf891 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 199 | 79 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-DC3-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.78e-05 | 199 | 79 | 5 | 7271dbeca9aa838b88ad44d00059263a29c0316b | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|World / Lineage, cell class and subclass | 2.78e-05 | 199 | 79 | 5 | 4de81f29c4d79868fd6254ceb81b4ddad22ae7d0 | |
| ToppCell | Macroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | 88d66550781a3c9102ff7455f5cff6fb072943cd | |
| ToppCell | Macroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | d6a059b0ef763c281c60b1ac76da6079ea822f80 | |
| ToppCell | Macroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | 16269fa4adb28fc6ed032bbdba8781237dd0d249 | |
| ToppCell | Macroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f | |
| ToppCell | Macroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.85e-05 | 200 | 79 | 5 | 79634b1086934412ae92f259ab43554ce545008f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.20e-05 | 129 | 79 | 4 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D231|Adult / Lineage, Cell type, age group and donor | 8.97e-05 | 132 | 79 | 4 | 8d30b71776f5f6da55dc78e0c5cb27be460004e3 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 139 | 79 | 4 | 2fdc8f36510aff24abbc79ef2a842db75a85f946 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 139 | 79 | 4 | 5970a654c64e3b54f9d18c102f5b125eec892fc5 | |
| ToppCell | PBMC-Mild-cDC_7|Mild / Compartment, Disease Groups and Clusters | 1.19e-04 | 142 | 79 | 4 | 58f66f35646f281e64d634e6c26adbd1d4e6c830 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 157 | 79 | 4 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-04 | 157 | 79 | 4 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 157 | 79 | 4 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.88e-04 | 160 | 79 | 4 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | BL-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.88e-04 | 160 | 79 | 4 | 3f737451d5713deed20061aa72a9ef77a9a2bc06 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.93e-04 | 161 | 79 | 4 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 161 | 79 | 4 | 8d2987271da52fd8353557ac6faa4f7a4be0ed2a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.02e-04 | 163 | 79 | 4 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 163 | 79 | 4 | 8569abb769543be55e066119c1dd1c505d5a177e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-04 | 164 | 79 | 4 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 165 | 79 | 4 | eeb58d4db64ad37dc6b441eab22b05c24862e1a9 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 165 | 79 | 4 | 6708beb0e8094f30cf5cd812e6a67a6db004a580 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 165 | 79 | 4 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-04 | 165 | 79 | 4 | 5f606959a060b1ae241217889560c6761ac73bbb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 167 | 79 | 4 | 0130743084dbcb20e10f96715d30961122150cbf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 167 | 79 | 4 | 7bcae3797d3a0811e7f39885afdfd29ec517f11b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 167 | 79 | 4 | c6f0209a1ad797631fdfa3efab6db6b1d3e8e315 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 168 | 79 | 4 | e870d2e69316406f45112ed0bf324b24f902a99e | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 168 | 79 | 4 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 168 | 79 | 4 | 403aba73a0f9ffb32252288d075fad8a588ca440 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.53e-04 | 173 | 79 | 4 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.53e-04 | 173 | 79 | 4 | 3d7c281a1a9f183a5a861d1a9c7b50d216535893 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.53e-04 | 173 | 79 | 4 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.53e-04 | 173 | 79 | 4 | 3aa90578371039f81b7c6fa873ec70f8f2bc7dfa | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 174 | 79 | 4 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.65e-04 | 175 | 79 | 4 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.65e-04 | 175 | 79 | 4 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.65e-04 | 175 | 79 | 4 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.76e-04 | 177 | 79 | 4 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 2.82e-04 | 178 | 79 | 4 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | (06)_Krt4/13+|World / shred by cell type and Timepoint | 2.82e-04 | 178 | 79 | 4 | 46efdf03aa1317bc600138e871509b995e773cce | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.95e-04 | 180 | 79 | 4 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.95e-04 | 180 | 79 | 4 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 181 | 79 | 4 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 182 | 79 | 4 | ef65b095f4240d61cfd4a59aec19d72d324dba1d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 182 | 79 | 4 | 97a805783a1f2b055c21307db250e3688674eff3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.07e-04 | 182 | 79 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 183 | 79 | 4 | 2df1611c8acccb2a6f233d3d68bd9df2381a7278 | |
| ToppCell | mild_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 3.14e-04 | 183 | 79 | 4 | 9a4899afac0f91203209392c5f67b3d0aa356b86 | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.20e-04 | 184 | 79 | 4 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-04 | 184 | 79 | 4 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-04 | 184 | 79 | 4 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.20e-04 | 184 | 79 | 4 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 184 | 79 | 4 | a7399a72f065d68800e3e0b2031d9894e0cc0ba4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-04 | 185 | 79 | 4 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-04 | 186 | 79 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.34e-04 | 186 | 79 | 4 | 71e87c4c755ab607689cb050f5a363cb520a0f53 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.34e-04 | 186 | 79 | 4 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.34e-04 | 186 | 79 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-04 | 186 | 79 | 4 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 186 | 79 | 4 | 18c06041c6c8a0ebac17b3c8aaebd67e652d315a | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.40e-04 | 187 | 79 | 4 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.40e-04 | 187 | 79 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-04 | 187 | 79 | 4 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-04 | 187 | 79 | 4 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.47e-04 | 188 | 79 | 4 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.47e-04 | 188 | 79 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| Drug | Amiodarone | CACNA1C TPST1 ABCA2 NRDC HPRT1 AHNAK EEPD1 TSPYL2 TXNDC16 PSMC5 CYP7B1 CAT ALAS1 ATP1A2 CLPX CPT1A EIF2AK3 PDZRN3 | 1.75e-06 | 1469 | 78 | 18 | ctd:D000638 |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.30e-06 | 198 | 78 | 7 | 5392_DN | |
| Drug | N-hydroxy-1-aminopyrene | 1.16e-05 | 2 | 78 | 2 | CID000114981 | |
| Drug | resokaempferol | 1.16e-05 | 2 | 78 | 2 | CID005281611 | |
| Disease | Grand Mal Status Epilepticus | 3.21e-05 | 67 | 79 | 4 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 3.21e-05 | 67 | 79 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 3.21e-05 | 67 | 79 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 3.21e-05 | 67 | 79 | 4 | C0751523 | |
| Disease | Petit mal status | 3.21e-05 | 67 | 79 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 3.21e-05 | 67 | 79 | 4 | C0393734 | |
| Disease | Status Epilepticus | 3.40e-05 | 68 | 79 | 4 | C0038220 | |
| Disease | Partial Fetal Alcohol Syndrome | 7.04e-05 | 5 | 79 | 2 | C3661483 | |
| Disease | Bonnevie-Ullrich Syndrome | 7.04e-05 | 5 | 79 | 2 | C1527168 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 7.04e-05 | 5 | 79 | 2 | C0814154 | |
| Disease | Turner Syndrome | 7.04e-05 | 5 | 79 | 2 | C0041408 | |
| Disease | Gonadal Dysgenesis, 45,X | 7.04e-05 | 5 | 79 | 2 | C0242526 | |
| Disease | Curling Ulcer | 1.05e-04 | 6 | 79 | 2 | C0010474 | |
| Disease | Alcohol Related Birth Defect | 1.05e-04 | 6 | 79 | 2 | C3146244 | |
| Disease | Duodenal Ulcer | 1.05e-04 | 6 | 79 | 2 | C0013295 | |
| Disease | protein-tyrosine sulfotransferase 2 measurement | 1.96e-04 | 8 | 79 | 2 | EFO_0801971 | |
| Disease | protein FAM177A1 measurement | 1.96e-04 | 8 | 79 | 2 | EFO_0801948 | |
| Disease | semaphorin-3G measurement | 1.96e-04 | 8 | 79 | 2 | EFO_0802049 | |
| Disease | Marfan Syndrome, Type I | 2.52e-04 | 9 | 79 | 2 | C4721845 | |
| Disease | hypertension (is_implicated_in) | 3.19e-04 | 121 | 79 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | Marfan Syndrome | 3.83e-04 | 11 | 79 | 2 | C0024796 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 3.93e-04 | 53 | 79 | 3 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 4.15e-04 | 54 | 79 | 3 | EFO_0022244 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 4.87e-04 | 57 | 79 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Reactive Hyperemia | 5.42e-04 | 13 | 79 | 2 | C0178824 | |
| Disease | lung disease (implicated_via_orthology) | 5.42e-04 | 13 | 79 | 2 | DOID:850 (implicated_via_orthology) | |
| Disease | Venous Engorgement | 5.42e-04 | 13 | 79 | 2 | C0042484 | |
| Disease | Fetal Alcohol Spectrum Disorders | 5.42e-04 | 13 | 79 | 2 | C2985290 | |
| Disease | leukemia (is_implicated_in) | 5.42e-04 | 13 | 79 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | Active Hyperemia | 5.42e-04 | 13 | 79 | 2 | C0333233 | |
| Disease | Hyperemia | 5.42e-04 | 13 | 79 | 2 | C0020452 | |
| Disease | cutaneous melanoma, hair color | 6.23e-04 | 62 | 79 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | actinic keratosis | 6.31e-04 | 14 | 79 | 2 | EFO_0002496 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 7.25e-04 | 264 | 79 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | response to olanzapine | 7.27e-04 | 15 | 79 | 2 | GO_0097333 | |
| Disease | Antibody Deficiency Syndrome | 9.38e-04 | 17 | 79 | 2 | C0003257 | |
| Disease | otitis media (biomarker_via_orthology) | 9.38e-04 | 17 | 79 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | Fetal Alcohol Syndrome | 9.38e-04 | 17 | 79 | 2 | C0015923 | |
| Disease | Gastric ulcer | 1.05e-03 | 18 | 79 | 2 | C0038358 | |
| Disease | neck circumference | 1.18e-03 | 19 | 79 | 2 | EFO_0011043 | |
| Disease | acetone measurement | 1.18e-03 | 19 | 79 | 2 | EFO_0010989 | |
| Disease | FEV/FEC ratio | STARD13 SPTBN5 LLGL2 PANK4 ETV6 LRRN2 UBASH3B SUFU MMP15 PDZRN3 | 1.60e-03 | 1228 | 79 | 10 | EFO_0004713 |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.61e-03 | 86 | 79 | 3 | EFO_0008595, EFO_0020945 | |
| Disease | influenza A (H1N1) | 1.67e-03 | 87 | 79 | 3 | EFO_1001488 | |
| Disease | Hypertensive disease | 1.72e-03 | 190 | 79 | 4 | C0020538 | |
| Disease | obsolete Mendelian syndromes with cleft lip/palate | 1.73e-03 | 23 | 79 | 2 | MONDO_0015335 | |
| Disease | Immunologic Deficiency Syndromes | 1.73e-03 | 23 | 79 | 2 | C0021051 | |
| Disease | Anhedonia | 1.88e-03 | 24 | 79 | 2 | C0178417 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.89e-03 | 91 | 79 | 3 | EFO_0004611, EFO_0005271 | |
| Disease | response to gemcitabine | 2.04e-03 | 25 | 79 | 2 | GO_0036272 | |
| Disease | Involutional paraphrenia | 2.04e-03 | 25 | 79 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 2.04e-03 | 25 | 79 | 2 | C1571984 | |
| Disease | Involutional Depression | 2.04e-03 | 25 | 79 | 2 | C0011574 | |
| Disease | response to TNF antagonist, joint damage measurement | 2.04e-03 | 25 | 79 | 2 | EFO_0004653, EFO_0005413 | |
| Disease | colorectal health | 2.11e-03 | 201 | 79 | 4 | EFO_0008460 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 2.38e-03 | 27 | 79 | 2 | EFO_0004629, EFO_0004630 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRELFVMAREHAPSI | 231 | P62195 | |
| RAMLDAHPDIRCGEE | 86 | O60507 | |
| HRLPREMIFVGRDDC | 16 | Q5SW79 | |
| IERKIMDHPGFREFC | 301 | Q9P2K9 | |
| EHFMPLLVQREEEGA | 31 | Q9Y6Q5 | |
| SLERGFCMAVREPDH | 46 | P16442 | |
| VFTDEMAHFDRERIP | 56 | P04040 | |
| HVEARDLIEFGMIPE | 481 | O76031 | |
| VGHFELRYIPDMETR | 261 | Q9NZJ5 | |
| ERHLAPEVFREIFGM | 741 | O14639 | |
| ALIMVPREVEDGGHE | 641 | Q01954 | |
| LVPEGCRFLHQERMD | 151 | P51693 | |
| RIPGEETDTIQHMRD | 316 | P50416 | |
| RELVGREMGVDVHFP | 5671 | Q09666 | |
| CHTVMVRESPRERPD | 571 | O60423 | |
| TRQEPMVRHEAGEAL | 81 | Q9BU89 | |
| REHGPFRSVEDLVRM | 166 | Q7L9B9 | |
| VMIHREEEGPVINFD | 311 | P59510 | |
| VEAHMRDACDARPVG | 126 | Q9UPQ7 | |
| ELLEDPVGRAHFMDF | 306 | O94810 | |
| CRRPDEDHIYQEEML | 1016 | P35228 | |
| EEHAMPIGRIADCRL | 326 | P41212 | |
| RVFEMVEALQEHPRD | 186 | Q6P1M3 | |
| EAGFPEVARMVRESH | 186 | O95872 | |
| CMRGLDPEEAHVIRF | 61 | Q8NE63 | |
| FCRRPLHFEVMSERE | 611 | P13196 | |
| RHDPLTVMDGVNRIV | 3651 | O95714 | |
| ATMVRDRQHGPVVEL | 4406 | O95714 | |
| IVCPMIDVIDHDDFR | 261 | Q86SR1 | |
| LPVREVPFREMTDHC | 406 | O75325 | |
| SILRDFMGCQEHVEP | 551 | P51511 | |
| FRERFEELLVFVPHM | 101 | Q9UBV7 | |
| HPEDTMKAFCRRELE | 576 | Q1X8D7 | |
| LEDDGERMVELRHPA | 286 | Q92817 | |
| VMVEPHRHEGVFICR | 86 | P22087 | |
| DRAVVDHMEPRVPAS | 341 | Q6B0I6 | |
| DRHELLIYEEVARMP | 356 | Q14168 | |
| HRRVEGFLCEVPAMI | 171 | O95371 | |
| DLERVFIPHGLIMDR | 31 | P00492 | |
| LIVAERIAGMDPVVH | 666 | Q9NVE7 | |
| RDPLIVEMARAGEIF | 651 | A1KZ92 | |
| EVGRTPIAMEIEHFI | 276 | P50993 | |
| PGARHFRELTEMEVG | 336 | Q53HC5 | |
| HVPMCEDLELRRDSG | 1866 | Q13936 | |
| VTEALRPFHERMEAC | 1586 | Q14185 | |
| ALDEHLFPVRIGDMR | 746 | Q96N67 | |
| RDMIPADVPEHFRGR | 301 | Q8IZJ3 | |
| RRFEETRGMEEEPTH | 971 | Q9BZC7 | |
| PCERTDIRMAIVADH | 4086 | Q12955 | |
| RCPERVMDLGLSEDH | 116 | Q6ZN54 | |
| CHPEAMEDFREKIRA | 411 | Q9P2N6 | |
| HPEAMAAVRDEIDRL | 311 | O75881 | |
| IMECDRLFEVPHELV | 861 | Q9Y3M8 | |
| GERARFCPRHEDMTL | 346 | Q15750 | |
| MFEVLVCDRIERGSH | 96 | Q8NFB2 | |
| MFEVLVCDRVERGTH | 96 | Q9H7F4 | |
| EMRERVLGPDHPDCA | 1121 | Q7Z494 | |
| LEDGEDVRRLPCMHL | 301 | Q6ZSG1 | |
| GERMEIVELEDHPFF | 506 | P17812 | |
| MEEIPCEIYVRGRED | 501 | Q8NC67 | |
| SPVEARRMLEEHQEC | 2501 | Q9NRC6 | |
| FLEHRVPAMTEEVAR | 66 | Q9Y2M2 | |
| AMLDAHPEVRCGEET | 86 | O60704 | |
| RKHDDDRRFMCPVEG | 476 | P98169 | |
| QPGVFDCLRDAMVRD | 111 | P43403 | |
| RAIGIPEHRAVMEAA | 166 | Q9P2K2 | |
| RGRCEVVIMEDAPDY | 416 | Q9H2G4 | |
| VPGARVDIMERQSHD | 141 | O15270 | |
| VERHMCDGDIVIFNR | 446 | P24928 | |
| TDMRRGETIFEIDPH | 236 | Q9UMX1 | |
| PCEHRTLEMVREFAG | 241 | Q5GFL6 | |
| HPLMIRDAIDREVEA | 296 | O43847 | |
| RHLVDETMDPFVDRI | 251 | Q5SRE5 | |
| VLHVEEAMVFCRELG | 161 | Q4G0T1 | |
| VMCHIEPDDGDDFVR | 111 | Q5JUR7 | |
| VEAEERIGRPVHEFM | 211 | Q8IUF8 | |
| DCVIVGSMAHPRRVE | 561 | Q9H967 | |
| EPTTRRHMAACEEFG | 461 | Q9H892 | |
| LFVCRHGERMDVVFG | 386 | Q8TF42 | |
| GRENVVVIHPDFRMI | 886 | A3KMH1 | |
| MEEGVSAVAHRIPCR | 341 | Q13488 |